Achira co-founder Theofanis Karaletsos (L) and CEO John Chodera
February 21, 2025 08:00 AM ESTUpdated 08:22 AM
Financing
AI

Nvidia-backed Achi­ra de­buts, blend­ing AI and physics to mod­el mol­e­cules

Andrew Dunn

Senior Biopharma Correspondent

As he was test­ing new an­tivi­rals to halt a fu­ture pan­dem­ic, John Chodera en­coun­tered an un­like­ly set of new prob­lems that ul­ti­mate­ly helped lead to …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Global Head of Marketing

Bachem

Bubendorf, BL, Switzerland

TRENDING NOW

CBER's deputy di­rec­tor de­parts as staff shake­up con­tin­ues

Blue­bird bio to sell to in­vest­ment funds af­ter strug­gling to make mon­ey from gene ther­a­pies

FDA ap­proves first drug to treat ul­tra-rare lipid stor­age dis­ease

Eli Lil­ly stock­piles $548M of oral weight loss drug ahead of launch

FDA says Ozem­pic, We­govy short­age is over

sponsored

Trust­ed pro­tec­tion: Why the cur­rent meningo­coc­cal vac­ci­na­tion sched­ule shouldn’t change with­out strong ev­i­dence

A service from the Financial Times